Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Princeton, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Oyster Point Pharma, Inc. has filed 280 SEC EDGAR filings since 25 Oct 2017

SEC filing history

Showing 201-225 of 280 matching filings.

Per page
25
Current page
9
UPLOAD

UPLOAD filing

Filing date
04 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS File 377-03142

DRS filing

Filing date
27 Apr 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39112

DEF 14A

Filing date
22 Apr 2020
Reporting date
22 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39112

DEF 14A

Filing date
22 Apr 2020
Reporting date
22 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39112

8-K

Filing date
30 Mar 2020
Reporting date
30 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39112

8-K

Filing date
27 Feb 2020
Reporting date
27 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Feb 2020
Reporting date
03 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Feb 2020
Reporting date
03 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Feb 2020
Reporting date
03 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39112

8-K

Filing date
14 Jan 2020
Reporting date
14 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39112

8-K

Filing date
13 Jan 2020
Reporting date
12 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39112

8-K

Filing date
03 Dec 2019
Reporting date
03 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91186

SC 13D

Filing date
14 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91186

SC 13D

Filing date
14 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91186

NEW ENTERPRISE ASSOCIATES 14, L.P. - OYSTER POINT PHARMA, INC. 13D

Filing date
08 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Nov 2019
Reporting date
04 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39112

8-K

Filing date
05 Nov 2019
Reporting date
30 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
05 Nov 2019
Reporting date
30 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Nov 2019
Reporting date
04 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Nov 2019
Reporting date
04 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Nov 2019
Reporting date
04 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Nov 2019
Reporting date
04 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 Nov 2019
Reporting date
04 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .